α1-Acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy

Journal of Medical Microbiology

Volumn 59, Issue 4, 2010, Pages 400-407

  Gupta, Nishma ^a,c   Shankernarayan, Nallakandy P ^b   Dharmalingam, Kuppamuthu ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b Leprosy Project   (India)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT; OROSOMUCOID; THALIDOMIDE; BIOLOGICAL MARKER; PROTEOME;

ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM LEPROSUM; FOLLOW UP; HUMAN; LEPROMATOUS LEPROSY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; BLOOD; ERYTHEMA NODOSUM; GLYCOSYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM; GLYCOSYLATION; HUMANS; LEPROSY, LEPROMATOUS; OROSOMUCOID; PROTEOME;

EID: 77950485785     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.016394-0     Document Type: Article

References (49)

1. Barnes, P. F., Chatterjee, D., Brennan, P. J., Rea, T. H. & Modlin, R. L. (1992). Tumor necrosis factor production in patients with leprosy. Infect Immun 60, 1441-1446.
2. Boutten, A., Dehoux, M., Deschenes, M., Rouzeau, J. D., Bories, P. N. & Durand, G. (1992). α1-Acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1β, interleukin-6 and tumor necrosis factor-α by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 22, 2687-2695.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
4. Bührer-Sékula, S., Sarno, E. N., Oskam, L., Koop, S., Wichers, I., Nery, J. A., Vieira, L. M., de Matos, H. J., Faber, W. R. & other authors (2000). Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis 68, 456-463.
5. Bührer-Sékula, S., Smits, H. L., Gussenhoven, G. C., van Leeuwen, J., Amador, S., Fujiwara, T., Klatser, P. R. & Oskam, L. (2003). Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 41, 1991-1995. (Pubitemid 36576525)
6. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orecchia, P., Zardi, L. & Righetti, P. G. (2004). Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333. (Pubitemid 38801651)
7. Ceciliani, F. & Pocacqua, V. (2007). The acute phase protein α1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci 8, 91-108. (Pubitemid 46322272)
8. De Graaf, T. W., Van der Stelt, M. E., Anbergen, M. G. & van Dijk, W. (1993). Inflammation-induced expression of sialyl Lewis X-containing glycan structures on α1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177, 657-666.
9. Faber, W. R., Iyer, A. M., Fajardo, T. T., Dekker, T., Villahermosa, L. G., Abalos, R. M. & Das, P. K. (2004). Serial measurement of serum cytokines, cytokine receptors and neopterin in leprosy patients with reversal reactions. Lepr Rev 75, 274-281. (Pubitemid 39362688)
10. Fassbender, K., Fassbender, M., Schaberg, T., Sobieska, M. & Muller, W. (1995). Glycosylation of α1-acid glycoprotein in bacterial lung infections: distinct pattern in tuberculosis. Clin Chem 41, 472-473.
11. Fournier, T., Medjoubi, N. N. & Porquet, D. (2000). α1-Acid glycoprotein. Biochim Biophys Acta 1482, 157-171.
12. Gilberts, E. C., Greenstein, A. J., Katsel, P., Harpaz, N. & Greenstein, R. J. (1994). Molecular evidence for two forms of Crohn disease. Proc Natl Acad Sci U S A 91, 12721-12724.
13. Girdhar, B. K., Girdhar, A. & Chakma, J. K. (2007). Advances in the treatment of reactions in leprosy. Indian J Lepr 79, 121-134.
14. Gupta, N., Shankernarayan, N. P. & Dharmalingam, K. (2007). Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. J Proteome Res 6, 3669-3679. (Pubitemid 47522756)
15. Hamerlinck, F. F., Klatser, P. R., Walsh, D. S., Bos, J. D., Walsh, G. P. & Faber, W. R. (1999). Serum neopterin as a marker for reactional states in leprosy. FEMS Immunol Med Microbiol 24, 405-409.
16. Hochepied, T., Berger, F. G., Baumann, H. & Libert, C. (2003). α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14, 25-34. (Pubitemid 36098429)
17. Irmak, S., Tilki, D., Heukeshoven, J., Oliveira-Ferrer, L., Friedrich, M., Huland, H. & Ergun, S. (2005). Stage-dependent increase of orosomucoid and zinc-a2-glycoprotein in urinary bladder cancer. Proteomics 5, 4296-4304. (Pubitemid 41626097)
18. Iyer, A., Hatta, M., Usman, R., Luiten, S., Oskam, L., Faber, W., Geluk, A. & Das, P. (2007). Serum levels of interferon-γ, tumour necrosis factor-α, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions. Clin Exp Immunol 150, 210-216. (Pubitemid 47609563)
19. Iyer, A., van Eijk, M., Silva, E., Hatta, M., Faber, W., Aerts, J. M. & Das, P. K. (2009). Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Clin Immunol 131, 501-509.
20. Izumi, S., Fujiwara, T., Ikeda, M., Nishimura, Y., Sugiyama, K. & Kawatsu, K. (1990). Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field. J Clin Microbiol 28, 525-529. (Pubitemid 20078128)
21. Jain, S., Rajput, A., Kumar, Y., Uppuluri, N., Arvind, A. S. & Tatu, U. (2005). Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India 53, 513-520. (Pubitemid 41282824)
22. Johnson, D. A. & Smith, K. D. (2006). The efficacy of certain antituberculosis drugs is affected by binding to α-1-acid glycoprotein. Biomed Chromatogr 20, 551-560.
23. Johnson, A. M., Hyltoft Petersen, P., Whicher, J. T., Carlstrom, A. & MacLennan, S. (2004). Reference intervals for serum proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK. Clin Chem Lab Med 42, 792-799. (Pubitemid 39137229)
24. Kahawita, I. P. & Lockwood, D. N. (2008). Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 102, 329-337.
25. Kleinert, P., Kuster, T., Arnold, D., Jaeken, J., Heizmann, C. W. & Troxler, H. (2007). Effect of glycosylation on the protein pattern in 2-D-gel electrophoresis. Proteomics 7, 15-22. (Pubitemid 46173712)
26. Kupcova, V., Turecky, L., Detkova, Z., Prikazska, M. & Keleova, A. (2003). Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease. Physiol Res 52, 89-93. (Pubitemid 36356265)
27. Lacunza, I., Kremmer, T., Diez-Masa, J. C., Sanz, J. & de Frutos, M. (2007). Comparison of α-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF. Electrophoresis 28, 4447-4451.
28. Lockwood, D. N. (2002). Leprosy elimination - a virtual phenomenon or a reality? BMJ 324, 1516-1518.
29. Martínez Cordero, E., González, M. M., Aguilar, L. D., Orozco, E. H. & Hernández Pando, R. (2008). Alpha-1-acid glycoprotein, its local production and immunopathological participation in experimental pulmonary tuberculosis. Tuberculosis (Edinb) 88, 203-211.
30. Misra, N., Murtaza, A., Walker, B., Narayan, N. P., Misra, R. S., Ramesh, V., Singh, S., Colston, M. J. & Nath, I. (1995). Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 86, 97-103.
31. Monot, M., Honore, N., Garnier, T., Araoz, R., Coppee, J. Y., Lacroix, C., Sow, S., Spencer, J. S., Truman, R. W. & other authors (2005). On the origin of leprosy. Science 308, 1040-1042.
32. Mortz, E., Krogh, T. N., Vorum, H. & Gorg, A. (2001). Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1, 1359-1363. (Pubitemid 33587891)
33. Nigam, P. K., Srivastava, P. & Patra, P. K. (2005). Serum adenosine deaminase levels in reactional and non-reactional leprosy. Indian J Dermatol Venereol Leprol 71, 20-22. (Pubitemid 40348227)
34. Oskam, L., Slim, E. & Buhrer-Sekula, S. (2003). Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74, 196-205. (Pubitemid 37205454)
35. Parkash, O. M., Girdhar, B. K. & Sengupta, U. (1993). Serum lactoferrin in lepromatous leprosy patients. Lepr Rev 64, 295-301.
36. Richardus, J. H. & Habbema, J. D. (2007). The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Lepr Rev 78, 330-337.
37. Ridley, D. S. (1988). Pathogenesis of Leprosy and Related Diseases. London: Wright.
38. Ridley, D. S. & Jopling, W. H. (1966). Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34, 255-273.
39. Saha, K., Bhatnagar, A., Sharma, V. K. & Chakrabarty, A. K. (1985). Enzyme immunoassay of serum β-2-microglobulin levels in various histological forms of leprosy with special reference to its elevation in type I and type II lepra reactions. J Clin Microbiol 21, 658-661. (Pubitemid 15106537)
40. Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R. L. & Bloom, B. R. (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282. (Pubitemid 21917341)
41. Silva, E. A., Iyer, A., Ura, S., Lauris, J. R., Naafs, B., Das, P. K. & Vilani-Moreno, F. (2007). Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Trop Med Int Health 12, 1450-1458. (Pubitemid 350212710)
42. Silva Miranda, M., Rodríguez, K. W., Martínez Cordero, E. & Rojas-Espinosa, O. (2006). Expression of cyclooxygenase-2, α1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy. Int J Exp Pathol 87, 485-494. (Pubitemid 44813867)
43. Steger, J. W. & Barrett, T. L. (1994). Military Dermatology, Part III: Disease and the Environment. Washington, DC: Office of the Surgeon General at TMM Publications, Borden Institute.
44. Su, S. J., Yang, B. C., Wang, Y. S. & Yeh, T. M. (1999). α1-Acid glycoprotein-induced tumor necrosis factor-a secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation. Immunopharmacology 41, 21-29.
45. Theophilus, S. (1980). Treatment with thalidomide in steroid dependency and neuritis. Lepr India 52, 423-428.
46. Turk, B. E., Jiang, H. & Liu, J. O. (1996). Binding of thalidomide to α1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor α production. Proc Natl Acad Sci U S A 93, 7552-7556. (Pubitemid 26277073)
47. Van Dijk, W., Brinkman-Van der Linden, E. C. M. & Havenaar, E. C. (1998). Glycosylation of α1-acid glycoprotein (orosomucoid) in health and disease: occurrence, regulation and possible functional implications. Trends Glycosci Glycotechnol 10, 235-245. (Pubitemid 128607115)
48. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R. & Modlin, R. L. (1991). Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277-279. (Pubitemid 21917340)
49. Young, D. B. & Buchanan, T. M. (1983). A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science 221, 1057-1059.